Clinical trials
Observational Hepatitis C trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2005 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 4 |
| Terminated | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 4 |
| Gilead Sciences | 3 |
| Bristol-Myers Squibb | 2 |
| AbbVie | 1 |
| Arbor Research Collaborative for Health | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Johane Allard | 1 |
| National Cancer Institute (NCI) | 1 |
| Unity Health Toronto | 1 |
| University Paris 7 - Denis Diderot | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 23 |
| Hepatitis B | 4 |
| Hepatitis C, Chronic | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Carcinoma, Hepatocellular | 2 |
| Fibrosis | 2 |
| Autoimmune Diseases | 1 |
| Cholangitis, Sclerosing | 1 |
| End Stage Liver Disease | 1 |
| Fatty Liver | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.